The objective of this study is to understand how spatiotemporal and kinetic gait parameters are associated with bone health in pwSMA who are receiving DMT. We …

Spinal Muscular Atrophy Type 3Ambulatory Spinal Muscular Atrophy

~Estimated

~$10 – $1,125

Jacqueline MontesNCT07400198

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

The purpose of this research is (1) to identify disease specific walking-related digital biomarkers of disease severity, and (2) monitor longitudinal changes i…

Spinal Muscular Atrophy Type 3Duchenne Muscular Dystrophy (DMD)

~Estimated

~$10 – $750

Columbia UniversityNCT06839469

← PreviousPage 2 of 2Next →